• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Regulus Therapeutics Inc. (RGLS)

    -NasdaqGM
    21.13 Up 2.59(13.97%) Mar 5, 3:59PM EST
    Add to Portfolio
    Prev Close:18.54
    Open:18.69
    Bid:21.28 x 400
    Ask:21.80 x 500
    1y Target Est:33.00
    Beta:1
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:18.54 - 21.22
    52wk Range:5.40 - 25.60
    Volume:1,735,657
    Avg Vol (3m):724,367
    Market Cap:1.07B
    P/E (ttm):N/A
    EPS (ttm):-1.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):122.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.07
    Quarterly EPS Est (Mar-15) :-0.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.46

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback